11 – 20 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Virtual screening for identifying a putative inhibitor of rmlc, a major target protein in tuberculosis disease
(
- Contribution to journal › Article
- 2013
-
Mark
Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules : comparison with (111)In-labeled counterparts
(
- Contribution to journal › Article
- 2012
-
Mark
On the estimation of ligand binding affinities
2012)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Inhibition mechanism of human galectin-7 by a novel galactose- benzylphosphate inhibitor
(
- Contribution to journal › Article
-
Mark
Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents
(
- Contribution to journal › Article
-
Mark
Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules
(
- Contribution to journal › Article
- 2011
-
Mark
Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines
(
- Contribution to journal › Article
- 2010
-
Mark
Design and synthesis of macrocyclic indoles targeting blood coagulation cascade Factor XIa
(
- Contribution to journal › Article
- 2002
-
Mark
Low micromolar inhibitors of galectin-3 based on 3'-derivatization of N-acetyllactosamine.
(
- Contribution to journal › Article
- 2001
-
Mark
Distance mapping of protein-binding sites using spin-labeled oligosaccharide ligands
(
- Contribution to journal › Article